Cubist Systematic Strategies, LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$269,615
-45.0%
46,167
-36.8%
0.00%
-33.3%
Q3 2022$490,000
+29.3%
73,068
-18.9%
0.00%
+50.0%
Q2 2022$379,000
+871.8%
90,123
+635.5%
0.00%
Q4 2021$39,000
-26.4%
12,254
-1.6%
0.00%
-100.0%
Q2 2021$53,000
-72.1%
12,452
-67.4%
0.00%
-50.0%
Q1 2021$190,000
+900.0%
38,151
+2441.7%
0.00%
Q4 2020$19,000
-32.1%
1,501
-46.7%
0.00%
Q3 2020$28,000
+2700.0%
2,817
+2929.0%
0.00%
Q2 2020$1,000
-99.5%
93
-99.5%
0.00%
-100.0%
Q2 2019$219,000
+69.8%
18,235
+70.9%
0.00%0.0%
Q1 2019$129,000
-72.8%
10,672
-41.8%
0.00%
-84.0%
Q4 2017$474,000
+577.1%
18,324
+287.5%
0.02%
+525.0%
Q3 2017$70,000
+288.9%
4,729
+165.2%
0.00%
+300.0%
Q3 2016$18,000
+38.5%
1,783
+57.2%
0.00%0.0%
Q2 2016$13,000
-67.5%
1,134
-61.4%
0.00%
-50.0%
Q1 2016$40,000
-51.2%
2,938
-46.4%
0.00%
-50.0%
Q2 2015$82,000
+8100.0%
5,486
+6431.0%
0.00%
Q1 2015$1,000
-99.5%
84
-99.4%
0.00%
-100.0%
Q4 2014$185,00013,8660.01%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Kynam Capital Management, LP 4,420,349$25,814,8383.96%
Parkman Healthcare Partners LLC 1,203,484$7,028,3471.87%
SPHERA FUNDS MANAGEMENT LTD. 1,002,783$5,856,2531.26%
TANG CAPITAL MANAGEMENT LLC 1,150,000$6,716,0000.98%
BVF INC/IL 3,629,000$21,193,3600.89%
Nantahala Capital Management 1,732,388$10,117,1460.66%
AWM Investment Company, Inc. 666,661$3,893,3000.56%
INGALLS & SNYDER LLC 1,295,833$7,5680.41%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 200,800$1,172,6720.36%
Kensington Investment Counsel, LLC 58,599$342,2180.27%
View complete list of CONCERT PHARMACEUTICALS INC shareholders